- Home
- SNY vs UBS Comparison
SNY vs UBS Comparison
Compare SNY & UBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SNY | UBS |
|---|---|---|
| Founded | 1994 | 1862 |
| Country | France | Switzerland |
| Employees | 74846 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.3B | 122.9B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | SNY | UBS |
|---|---|---|
| Price | $47.77 | $42.72 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | $58.00 | ★ $60.30 |
| AVG Volume (30 Days) | ★ 2.9M | 2.5M |
| Earning Date | 04-23-2026 | 04-29-2026 |
| Dividend Yield | ★ 3.33% | 1.28% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $3.86 | $7.68 |
| Revenue Next Year | $5.64 | $2.97 |
| P/E Ratio | ★ $6.14 | $17.22 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $43.32 | $27.40 |
| 52 Week High | $55.73 | $49.36 |
Technical Indicators
Market Signals| Indicator | SNY | UBS |
|---|---|---|
| Relative Strength Index (RSI) | 58.76 | 65.24 |
| Support Level | $46.88 | $41.24 |
| Resistance Level | $48.49 | $48.90 |
| Average True Range (ATR) | 0.71 | 0.75 |
| MACD | 0.12 | 0.62 |
| Stochastic Oscillator | 74.45 | 89.85 |
Price Performance
Historical ComparisonAbout SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
About UBS UBS Group AG Registered
UBS is a global financial institution built around its core strength in wealth management, serving high and ultra-high-net-worth individuals. In Switzerland, it also operates as a traditional retail and commercial bank. Its investment bank and asset management divisions complement the wealth business, providing tailored solutions to UBS clients while serving third-party customers by leveraging UBS' global reach and expertise.